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We report herein that vesicular stomatitis virus (VSV) induced a concurrent primary Th1 (T helper 1) and Th2 cytokine response
detectable ex vivo. Liposome-encapsulated clodronate-mediated elimination of CD8 marginal dendritic cells (DCs) and splenic
macrophages (mA), but not CD8+ interdigitating DCs, prior to infection resulted in a markedly diminished chemokine and Th1 (IL-2,
interferon-g) cytokine response, although the Th2 response (IL-4) remained relatively intact. Repopulation with marginal DCs and marginal
metallophilic macrophages (MMM) restored Th1 cytokine profiles but did not restore chemokine responsiveness or reduce VSV-induced
morbidity/mortality. Chemokine competency returned approximately 4 weeks post-depletion, which correlated temporally with repopulation
of the spleen with marginal zone macrophages (MZM) and red pulp macrophages (RPM). Unexpectedly, virus-induced morbidity persisted
for over 1 month post-depletion and was associated with virus dissemination and distinctive histological lesions in the liver. Depletion of
interferon-producing plasmacytoid dendritic cells did not account for virus-induced morbidity because serum levels of type I interferon were
not diminished in Cl2MBP-liposomesome-treated mice. Thus, distinct mA subsets are critical for chemokine production and viral clearance,
and, in their absence, VSV disseminates even in the presence of high titers of interferon.
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Antiviral immunity depends upon complex and cooper-
ative interactions between different components of the
innate and adaptive immune response that cannot be
accurately duplicated in vitro. In vivo, this response is
orchestrated in part by elaborated chemokines and cytokines
that control the migration and activation of both inflamma-
tory cells and antiviral T cells. In addition, contact-depend-
ent signals delivered to CD8+ CTLs by dendritic cells (DCs)
and helper T (Th) cells are required for optimal antiviral
CTL responses. Thus, depletion of CD4+ cells by genetic0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.07.031
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E-mail address: ciavarrp@evms.edu (R.P. Ciavarra).manipulation (Karupiah et al., 1996; Shedlock and Shen,
2003) or infusion of anti-CD4 monoclonal antibody (mAb)
dramatically suppresses recall CTL responses in vitro and in
vivo, demonstrating that CTL priming is CD4-dependent
(Ciavarra and Tedeschi, 1994; Shedlock and Shen, 2003;
Sun and Bevan, 2003).
The spleen represents an important and convenient
lymphoid organ to study the complex interplay between
cells of the innate and adaptive immune response. Bone-
marrow-derived macrophage (mA) precursors migrate to
specific splenic compartments where they likely undergo
further differentiation and function. Several morphologically
distinct and compartmentalized mA subpopulations have
been described in the murine spleen, such as red pulp
macrophages (RPM), marginal metallophilic macrophages05) 177 – 189
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macrophages (WPM) (Kraal, 1992). However, it has been
difficult to study collaborative interactions between these
cells and the adaptive immune system because defects
affecting the innate immune system, particularly macro-
phages or neutrophils, often compromise the host immuno-
logically and are lethal early in development or shortly after
birth. To circumvent these complications, acute depletion has
been performed employing liposome-entrapped dicloro-
methylene biphosphonate (Cl2MBP-liposome, clodronate).
This suicide approach demonstrated that depletion of
phagocytic cells markedly suppressed immune responses to
both complex pathogens and simple protein antigens (Buit-
ing et al., 1996; Cua et al., 1995; Delemarre et al., 1990;
Karupiah et al., 1996; Matsushima and Stohlman, 1991).
Previous reports indicated that Cl2MBP-liposome treat-
ment depleted splenic mA and dendritic cells (DCs) in the
marginal sinus (marginal dendritic cells) and markedly
suppressed priming for a secondary anti-VSV Th cell and
CTL response in vitro (Ciavarra et al., 1997; Leenen et al.,
1998). Subsequent antigen pulse experiments demonstrated
that splenic DCs, but not splenic mA, processed and
presented VSV peptide/class I and II complexes in situ,
even though mA effectively functioned as antigen present-
ing cells (APC) for VSV T cells in vitro (Ciavarra et al.,
2000). Depletion of marginal DCs and splenic mA did not
prevent the accumulation of VSV peptide/class I and II
complexes on the remaining CD8+ interdigitating DC
population reported to be resistant to liposome-mediated
elimination (Leenen et al., 1998). This suggests that
interdigitating DCs can process and present VSV peptides
in vivo independent of marginal DCs and other splenic mA
subpopulations (Ciavarra et al., 2000). However, it remains
to be determined whether interdigitating DCs alone can
induce functional development of antiviral T cells.
The present study examines the contribution of splenic DC
and mA subpopulations on antiviral immunity and host
resistance. The data indicate that: (i) CD8+ DCs are not
sufficient to induce a primary antiviral Th1 cytokine re-
sponse; (ii) virus-induced chemokine production is depend-
ent on mA with slow repopulation kinetics; (iii) depletion
of splenic plasmacytoid DCs does not diminish serum type
I interferon (IFN) titers; (iv) in the absence of splenic mA,
VSV disseminates ubiquitously even in the presence of
high serum titers of IFN. Thus, distinct mA subpopulations
play a critical role in host resistance and antiviral immunity
most likely by preventing early virus dissemination.Results
Characterization of the primary anti-VSV Th1 and Th2
cytokine response in vivo
To generate a primary anti-viral type 1 (IL-2) or type 2
(IL-4) cytokine response in vivo, naive mice were given asingle injection of either 2  107 or 50  107 plaque
forming units (PFU) VSV. At the indicated times post-
infection (p.i.), spleen cells were cultured overnight in
ELISPOT plates. Few IL-2- or IL-4-producing cells were
detected in mock-infected mice (data not shown). How-
ever, in mice infected with 2  107 PFU VSV, the
frequency of IL-2-producing cells increased with time,
peaking on days 4 or 5, and then declined slowly with
cytokine-producing cells still detectable 12–14 days p.i.
(Figs. 1A and B and data not shown). Similar kinetics
were detected when IFN-g (data not presented) and IL-4
responses (panels C and D) were evaluated. The frequen-
cies of IL-4- and IL-2-secreting cells were approximately
the same at the various time points tested, indicating that
the IL-4 response was not a minor component of the anti-
viral cytokine response and occurred in the presence of
an ongoing Th1 response in vivo. The decline in the
number of cytokine-producing cells was due in part to
VSV-induced replication of cells not secreting cytokines.
This dilution effect is eliminated when data are expressed
as the frequency of cytokine-secreting cells/spleen (panels
B and D).
The VSV-induced IL-2 response was dose-dependent
because 50  107 PFU markedly increased (P = 0.001)
the frequency of IL-2-secreting cells, although a 25-fold
increase in infective dose did little to accelerate the
kinetics of this response (panel A). This high dose of
virus also induced a strong proliferative response in the
spleen (data not shown), which accounts for the increase
in the total number of IL-2 secreting cells (panel B). A
smaller viral dose (1  106 PFU) did not elicit a
detectable primary anti-VSV IL-2 response (data not
shown). IL-2- and IL-4-producing cells were nylon wool
non-adherent (NW/NA) and were positively selected with
anti-CD4 mAb and magnetic beads (panel E and data not
shown). Furthermore, treatment with anti-CD4 but not
anti-CD8 mAb plus complement (C) markedly reduced
the frequency of IL-2-producing cells (panel E). Addi-
tional depletion/enrichment experiments indicated that
CD4+ T cells also mediated VSV-induced IL-4 and
IFN-g responses (data not presented). The frequency of
IL-2-secreting cells was unexpectedly low in fractions
enriched for T cells relative to the complement control
group. This may have reflected the loss of accessory cells
eliminated during T cell isolation that were required for
optimal cytokine secretion during overnight incubation in
ELISPOT plates. Collectively, these characteristics indi-
cate that VSV induces a primary Th1 (IL-2, IFN-g) and
Th2 (IL-4) cytokine response mediated in vivo by CD4+
Th cells.
Elimination of phagocytic cells inhibits the primary
VSV-induced T helper 1 cytokine response
Administration of Cl2MBP-liposomes ablates splenic
macrophages and marginal DCs but leaves interdigitating
Fig. 2. Acute depletion of phagocytic cells inhibits a primary anti-VSV Th1, but not a Th2, cytokine response in vivo. Mice were treated with either PBS- or
Cl2MBP-entrapped liposomes, infected i.p. with 2  107 PFU VSV, and evaluated for the indicated cytokines by ELISPOT assay 6 days p.i. In this experiment,
the response of mock (filled bars)- and VSV-infected control mice (stippled bars) treated with PBS-liposomes represents the average of two mice. Two mice
(open and diagonal striped bars) were treated with Cl2MBP-liposomes prior to VSV infection and their individual responses plotted. No exogenous virus was
added during the overnight incubation of cells in the ELISPOT plate. **, Significant at P < 0.01 when compared to PBS-liposome-treated and VSV-infected
mice. ns, not significant (P > 0.06) when compared to mice treated with liposome-entrapped PBS and then infected with VSV. Data are representative of six
independent experiments.
Fig. 1. Kinetics of the primary anti-VSV IL-2 and IL-4 cytokine responses in situ. (A and B) Spleen cells, obtained from mice infected i.p. at different times
with either 2  107 (open circles) or 50  107 PFU VSV (closed circles), were diluted into ELISPOT plates and incubated overnight in the absence of
exogenous virus. Each input cell number was plated in quadruplicate, and each time point represents the average response of 2–3 animals. The number of IL-2-
producing cells in mock-infected mice was <5/106 spleen cells and <250/spleen (data not presented). (C and D) Mice were either mock- or VSV-infected and
IL-4 (open circles)- and IL-2 (closed circles)-secreting cells estimated by ELISPOT assay. IL-4-secreting cells detected in mock-infected mice were 10
ELISPOTS/106 spleen cells and <450/spleen. (E) Mice were infected with VSV, and 5 days later, spleen cells were subjected to the indicated treatments. CD4+
cells were positively selected using anti-CD4 mAb/GK1.5 (American Type Culture Collection, Manassas, VA) and anti-rat IgG-coated magnetic beads
following the manufacturer’s instructions (Miltenyi Biotec Inc., Auburn, CA). Depletion of CD4+ or CD8+ T cells was achieved with rabbit complement (Pel-
Freez, Brown Deer, WI) and mAb to either CD4+ (RL172-4) or CD8 (41-3.48) obtained from American Type Culture Collection. Values reported represent the
mean of triplicate determinations T SD. The experiment is representative of three independent experiments.
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that elimination of these cells markedly suppressed the
VSV-induced Th1 cytokine response (panels A, B, D, E)
both in terms of frequency (ELISPOTS/106 cells) and
total number (ELISPOTS/spleen) of type 1 cytokine-
secreting cells. PBS-entrapped liposomes did not
adversely effect phagocytic cells because mice mounted
both a Th1 (IL-2, IFN-g) and a Th2 (IL-4) response that
was equivalent to that detected in mice treated with PBS
(Fig. 2 and data not shown). In contrast, the frequency
and total number of IL-4-producing cells were similar in
PBS and Cl2MBP-liposome-treated mice (panels C and
F). These data suggest that interdigitating DCs are not
sufficient to induce Th1 cytokine-producing cells follow-
ing VSV infection despite cell surface expression of
VSV peptide/class II complexes in vivo (Ciavarra et al.,
2000).Fig. 3. Inability of interdigitating dendritic cells to induce a VSV-induced chemok
liposome-entrapped Cl2MBP (right panels), rested 7 days and their spleen cells p
stained with anti-CD11c (abscissa) and anti-I-Ad (ordinate) (a, b) to detect DCs
presence of RPM (c, d), MMM (e, f) and MZM (g, h). In a separate but representat
CD8a, I-Ad and B7.2, and the results summarized in panel B. The distribution of
animals is presented in panel C. In panels B and C, open and filled hatched bars rep
and Cl2MBP-liposome-treated mice were rested for 7 days and then infected with V
for the indicated chemokine mRNA. Each lane was loaded with 5 Ag RNA isolate
VSV-infected mice treated 7 days previously with Cl2MBP-liposomes (lane 5). Th
respectively. The gel was deliberately overexposed to highlight chemokine bands. R
For this and all subsequent experiments, films were also underexposed to insure
gels were then used to correct for any differences in the amount of RNA loaded
results.Interdigitating dendritic cells are not sufficient for a
VSV-induced chemokine response
To determine whether CD8+ DCs were sufficient for
chemokine production, chemokine mRNA levels were
examined in mice treated with Cl2MBP-liposomes. Fig. 3
demonstrates that this suicide technique markedly reduced
the number of CDllc+I-Ad+ DCs but did not deplete CD8+
DCs (panels A and B), confirming prior immunohistochem-
ical studies. In contrast, CD8 marginal DCs were
profoundly depleted as were mA that reside in the red pulp
and marginal sinus (panels A–C). The numbers of T, B and
NK cells in the spleen were not altered by this treatment
(data not shown). VSV infection induced elevated levels of
CC chemokines RANTES (CCL5), MIP-1a (CCL3), MIP-
1h (CCL4) and the CXC chemokine MIP-2 (CXCL1) in
control mice treated with PBS (panel D). In contrast, miceine response in vivo. (A) Mice were treated with either PBS (left panels) or
henotyped for DC and mA subpopulations by flow cytometry. Cells were
. Single-color flow cytometry was used to phenotype spleen cells for the
ive experiment, dendritic cell subsets were characterized using antibodies to
class II antigens and costimulatory molecules on RPM (F4/80+) from these
resent mice infused with PBS or Cl2MBP-liposomes, respectively. (D) PBS-
SV. Two days later, spleens were removed, total RNA isolated and assessed
d from mock-infected mice (lane 3), VSV-infected control mice (lane 4) or
e probe set (mCK5) and control mouse RNAwere loaded in lanes 1 and 2,
elative band densities were normalized with L32, a housekeeping gene (E).
that housekeeping gene bands were in the linear range of the film. These
in each lane. This experiment has been repeated twice and yielded similar
R.P. Ciavarra et al. / Virology 342 (2005) 177–189 181treated with Cl2MBP-liposomes failed to mount a detectable
chemokine mRNA response. These data indicate that
interdigitating DCs are not sufficient to generate a VSV-
induced chemokine response.
Splenic repopulation with marginal dendritic cells and
marginal metallophilic macrophages fails to render mice
competent to produce chemokines
If animals were rested an additional week after Cl2MBP-
liposome treatment, the spleen became repopulated with
normal numbers of DCs composed of approximately equal
numbers of B7.2+ and B7.2 DCs (Fig. 4A). Red pulp
macrophage (F4/80+) and MMM (MOMA-1+) numbers
were approximately 60% of control values (panel B).
However, staining with SER4+, a mAb also specific for
MMM, indicated that MMM were present in normal
numbers (panel B). The reason for this discrepancy is not
clear, but we note that the MOMA-1 antigen distributes both
in the cytosol and plasma membrane (Kraal and Janse,
1986), while the SER-4 antigen is exclusively a cell surface
molecule (Crocker et al., 1990). At this time point, the
spleen also contained markedly reduced numbers of MZMFig. 4. Repopulation of the spleen with marginal dendritic cells and marginal zone
B) Mice were injected with either PBS or Cl2MBP-liposomes, and 14 days later,
presence of DCs (A) and mA subpopulations (B). (C) Chemokine mRNA levels i
then infected with VSV. Two days p.i., total spleen cell RNA was isolated and ch
Protected bands were identified by gel electrophoresis of RNA (5 Ag/lane) isolated
Cl2MBP-liposomes (lane 5) or PBS (lane 6). Lane 1 contains mCK5 probe set, lan
presentation of the gel data presented in panel C illustrating relative band intens
Cl2MBP-liposomes (closed circles) 2 weeks prior to infection with VSV. Similar ch(ERTR9+) confirming prior kinetic studies that MZM
repopulated the spleen with the slowest kinetics. Despite
normal numbers of marginal DCs and MMM, only the
VSV-induced MIP-2 response was normal with mRNA
levels of the remaining chemokines below mock-infected
levels (panels C and D). We also observed in this and the
previous study that mice became moribund (ruffled fur,
pinched-in sides, weight loss) around 48 h post-VSV
infection. We therefore monitored survival of cohorts and
observed that the majority of these mice subsequently died
between days 4 and 5 p.i. (panel E).
Reconstitution of chemokine response is dependent on
macrophages with slow repopulation kinetics
Spleens from mice rested 3 weeks following Cl2MBP-
liposome treatment were still markedly deficient in RPM and
MZM (Figs. 5A–D). Chemokine mRNA profiles indicated
that mRNA levels for RANTES remained suppressed,
whereas CXCL1 mRNA levels exceeded the response
present in VSV-infected control mice (panels E and F). A
similar but less impressive increase was also seen for CCL3,
CCL4 and CCL1 (TCA-3). Spleens remained small withmacrophages fails to restore the VSV-induced chemokine response. (A and
spleen cells were phenotyped by one- and two-color flow cytometry for the
n mice treated with either PBS- or Cl2MBP-liposomes, rested 14 days and
emokine mRNA levels determined by multi-probe RNase protection assay.
from mock-infected mice (lane 4) or VSV-infected mice treated with either
e 2 is empty and lane 3 was loaded with control mouse RNA. (D) Graphic
ities. (E) Mortality rate of mice treated with either PBS (open circles) or
emokine profiles were obtained in two additional independent experiments.
Fig. 5. Dysregulated chemokine profile appears 3 weeks post-Cl2MBP-liposome treatment. (A–D) Three weeks after administration of either PBS or Cl2MBP-
liposomes into normal mice, spleen cells were examined for the presence of DCs and the indicated mA subpopulations by two-color flow cytometry. (E) Mice
were injected with either PBS or Cl2MBP-liposomes and 3 weeks after treatment infected with VSV. Chemokine mRNA profiles were then determined as
described above. The gel presented in panel E reveals the RNA protected bands detected when the probe was hybridized with 5 Ag RNA isolated from mock-
infected mice (lane 1), mice treated with PBS and infected with VSV (lane 2) and mice treated with Cl2MBP-liposomes and infected with VSV (lane 3). Lanes
4 and 5 represent control mouse RNA and probe set, respectively. The relative band intensities for each chemokine are plotted in panel F. (G) Survival of mice
treated with either PBS (open circles) or Cl2MBP-liposomes (closed circles) and 21 days later injected with VSV. Data are representative of five independent
experiments.
R.P. Ciavarra et al. / Virology 342 (2005) 177–189182reduced cellularity (X = 3.1  107/spleen, n = 4) relative to
VSV-infected mice or mice treated similarly with Cl2MBP-
liposomes but not infected with VSV (range 8–11  107/
spleen, n = 6). A 3-week rest period was not sufficient for
mice to regain resistance to a sublethal dose of VSV because a
substantial fraction of cohorts died following virus infection
(Fig. 5G).
With the exception of CXCL1 (MIP-2) which remained
elevated, a normal VSV-induced chemokine mRNA profile
was eventually achieved 32 days post-Cl2MBP-liposome
treatment (Figs. 6A and C). Despite normal chemokine
mRNA profiles, liposome-treated mice became moribund
2–3 days after VSV infection with an ¨50% mortality rate
(panel D). Together, these data suggest that slowly
repopulating MZM and/or RPM are required to generate a
VSV-induced chemokine response in vivo.Depletion of phagocytic cells promotes systemic virus
replication
Because ablation of phagocytic cells was associated with
acute illness, virus titers were evaluated in several organs.
As expected, virus infection of control (PBS injected) mice
did not result in detectable VSV titers in brain, lung, liver or
spleen 2 days post-infection (Fig. 7). In contrast, VSV
replicated in lung, liver and spleen of mice treated 7 days
previously with Cl2MBP-liposomes. Virus was also detect-
able in the brain, although titers were low relative to the
other organs sampled. Delaying virus infection to allow
return of marginal DCs and MMM (day 14) did not reduce
viral loads. Indeed, some mice rested for 3 or 4 weeks prior
to virus infection still failed to clear VSV 48 h post-
infection. At autopsy, gross discoloration of the liver was
Fig. 6. Chemokine competence does not prevent VSV-induced morbidity and mortality. (A) Mice were treated with Cl2MBP-liposomes and rested for 32 days
before spleen cells were phenotyped by single-color flow cytometry for the indicated mA population. (B) Chemokine profiles were determined for mice treated
with either PBS or Cl2MBP-liposomes, rested for 32 days and then infected with VSV. The gel presented in panel B illustrates the chemokine mRNA protected
bands when each lane was loaded with RNA derived from one of the following groups: lane 1, mock-infected mice at 8 Ag/lane; lanes 2–4, mice treated with
PBS and VSV-infected at 2, 4 and 8 Ag/lane, respectively; lanes 5–7, mice treated with Cl2MBP-liposome and VSV-infected at 2, 4 and 8 Ag/lane,
respectively; lane 8, control mouse RNA; lane 9, empty; lane 10, probe set. Individual chemokine bands in each lane were quantified and the band intensity
relative at 4 Ag/lane to L32 plotted in panel C. (D) Survival of cohorts treated with either PBS or Cl2MBP-liposomes, rested for 32 days and then infected with
VSV. This experiment was repeated a second time and yielded similar results.
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and infected with VSV. Histological evaluation revealed
acute necrotizing hepatitis characterized by random, often
coalescing foci of necrosis associated with mild neutrophilic
infiltrates (panel B). Interestingly, a second distinct lesion
was observed where hepatocytes were relatively intact
except in areas adjacent to portal veins (panel C). However,
portal vein thrombosis with a neutrophilic leukocytoclastic
infiltrate was common throughout the section, while bile
ducts and hepatic arteries were spared.
Impact of Cl2MBP-liposome treatment on plasmacytoid
dendritic cells and interferon production
The failure to control viral dissemination may simply
reflect liposome-mediated depletion of interferon-producing
pDCs. In control animals, pDCs represented ¨10–20% of
the total splenic CD11c+ population with the vast majority
expressing class II antigens and variable expression of
costimulatory molecules B7.1/2 (Fig. 8A). Although pDCs
could still be detected in the spleen of mice infused with
Cl2MBP-liposomes, their numbers were markedly reduced7 and 14 days post-treatment but returned to normal values 1
week later (panels A and B). Based on these data and a prior
report that pDCs are the only detectable interferon-
producing cells in the spleen of VSV-infected animals
(Barchet et al., 2002), we speculated that IFN levels should
be dramatically reduced in Cl2MBP-liposome treated mice.
However, sera from these mice contained IFN titers that
were actually higher on days 7 and 14 than those detected in
control mice (panel C). These data indicate that elimination
of pDCs does not diminish the host’s capacity to produce
type I IFN in response to infection with VSV.
A normal Th1 cytokine profile is not sufficient to prevent
virus dissemination
It is apparent that the ability of the host to produce
chemokines and IFN does not insure resistance to VSV.
We therefore considered the possibility that persistent
virus dissemination reflected the inability to generate
protective Th1 cytokines even after several weeks of
recovery following Cl2MBP-liposome treatment. To test
this hypothesis, the VSV-induced Th1 cytokine response
Fig. 7. Ablation of phagocytic cells is associated with inefficient viral clearance and distinct liver lesions. (A) Mice were treated with either PBS (open circles)
or Cl2MBP-liposomes (filled circles), rested for the indicated times and then infected with VSV. Two days after infection, lysates of spleen, liver, lung and
brain were prepared and assayed for VSV PFU on permissive Vero cells. Samples of liver were also prepared for histopathology. (B and C) Histological
features in livers of mice treated with Cl2MBP-liposomes 21 days previously and infected with VSV. An acute hepatitis is apparent in panel B. Lines point to
focal areas of necrosis (a) but uninvolved portal veins (b). In panel C, hepatocytes are preserved except in areas adjacent to portal triads (C). In this section, two
thrombi are seen occluding a hepatic vein (a). The adjacent bile duct (b) is not involved nor is the hepatic artery (not shown). Sections were stained with
hematoxylin and eosin and viewed at a 10 magnification.
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tion with Cl2MBP-liposomes. Fig. 9A demonstrates that
mice were not capable of producing Th1 cytokines fol-
lowing infection with VSV 1 week after depletion. A
profound loss of cellularity was also noted that markedly
reduced the total number of splenic cytokine-secreting cells
(panel B). However, when mice were allowed to recover
an additional week, normal numbers of cytokine-producing
cells (panel C) and cellularity (panel D) were detected
in the spleen. Thus, failure to control virus replication
cannot be attributed solely to a suppressed Th1 cytokine
response.Discussion
We report herein that VSV infection induced a reprodu-
cible primary Th1 (IL-2, IFN-g) and Th2 (IL-4) cytokine
response in vivo that was detected without further antigenrestimulation in vitro. Type I (IL-2, IFN-g) and 2 (IL-4)
cytokine responses displayed similar protracted kinetics in
that both responses peaked between days 4 and 5 and
remained elevated above mock-infected levels for several
weeks post-infection. This prolonged response occurred
despite rapid clearance of VSV T cell epitopes within 72 h
post-infection (Ciavarra et al., 2000). We were unsuccessful
in generating a similar primary response in vitro with VSV-
infected DCs and naive T cells (data not presented). Cell
fractionation and depletion experiments indicated that CD4+
T cells were the primary source of all cytokines tested.
Cytokine-producing CD8+ cells were not detected even after
challenge of VSV-immune mice (data not presented). When
mice were depleted of phagocytic cells by liposome-
mediated delivery of Cl2MBP prior to VSV infection,
prototypical Th1 cytokines such as IL-2 and IFN-g were
profoundly inhibited, whereas IL-4 production was not
diminished significantly. This suggests that interdigitating
DCs, the only splenic APC population remaining after
Fig. 8. Impact of Cl2MBP-liposome treatment on plasmacytoid dendritic cells and serum interferon levels. (A) Mice were treated with either PBS or liposome-
encapsulated Cl2MBP, rested for the indicated times before spleen cells (pooled from 3 mice/treatment) were phenotyped for pDCs by multiparameter flow
cytometry. Gates were first set on CD11c+Gr-1+ cells and then co-expression of B7.1, B7.2 and I-Ad determined on CDllc+Gr-1+CD45R(B220)+ pDCs. (B)
Data presented in panel A plotted as percentage of pDCs in the spleen at the indicated times following Cl2MBP-liposome treatment. (C) Mice were treated with
either PBS (open circles) or Cl2MBP-liposomes (filled circles) and at the indicated times infected with VSV (2  108 PFU). The following day (12–15 h post-
infection), serum IFN titers were determined by virus neutralization using mouse L cells. Values represent means T SEM of 2–5 mice per time point. This
experiment is representative of three independent experiments.
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induce IL-4 cytokine production. In contrast, production of
Th1 cytokines during infection with VSV appears to be
dependent on one or several of the depleted phagocyticFig. 9. Resistance to virus dissemination is not associated with a normal Th1 cyt
Cl2MBP-liposomes and rested either 7 (A and B) or 14 days (C and D) before infe
by ELISPOT assay.populations. The most likely candidate for this function is the
marginal DCs because they display VSV-derived peptides in
vivo and repopulate the spleen 2 weeks post-depletion, a
time when Th1 cytokine production returns to normal.okine profile. Mice were depleted of phagocytic cells by administration of
ction with VSV. Six days later, mice were evaluated for cytokine production
R.P. Ciavarra et al. / Virology 342 (2005) 177–189186A current paradigm suggests that Th cell polarization is
mediated by DCs. Implicit in this model is the notion that
Th1 versus Th2 differentiation may be fixed immutably for
each DC subset (De Smedt et al., 2001; Maldonado-Lopez
et al., 1999). However, accumulating evidence suggests that
bacterial compounds markedly influence the polarizing
potential of DCs (de Jong et al., 2002; Huang et al., 2001;
Whelan et al., 2000). Viral pathogens, such as herpes
simplex virus and influenza virus, appear to regulate DC
differentiation in a similar fashion (Kadowaki and Liu,
2002; Lopez et al., 2001). If microbial products do regulate
DC effector cell development and subsequent Th cell
polarization as these studies suggest, it is difficult to explain
how a single pathogen such as VSV can induce polarizing
DCs. However, interdigitating and marginal DCs are located
in distinct splenic microenvironments, and they are likely
exposed to different VSV-induced chemokine/cytokine
signals which may influence DC differentiation pathways
during VSV infection. Dendritic-cell-mediated Th cell
polarization appears to be the case with VSV because
depletion of myeloid DCs markedly suppressed Th1
cytokine production, and the loss of this response was
associated with virus dissemination and morbidity. This
suggests that the generation of a normal Th1 cytokine
profile is protective and depends on the presence of myeloid
DCs. The temporal correlation of normal Th1 cytokine
response and splenic repopulation with myeloid DCs
support the view that this response is driven by this DC
subset. However, the ability to generate this response did
not prevent virus dissemination and associated morbidity/
mortality. Ongoing studies utilizing tetramers indicate that
clonal expansion of CD8+ VSV-specific T cells is only
marginally inhibited in mice treated with Cl2MBP-lip-
osomes including moribund mice with a heavy viral load.
This may reflect the ability of CD8+ interdigitating DCs to
induce T cell clonal expansion. However, upregulation of
VLA-4 is suppressed on tetramer+ cells, as is the number of
granzyme+ cells (unpublished observation). Thus, develop-
ment of effector T cells may be dependent on further
polarization of marginal DCs induced by chemokine signals
derived from repopulating macrophages. This view is
supported by studies demonstrating that chemokines can
regulate subsequent T cell functions in mice infected with
viral pathogens (Salazar-Mather et al., 2000). As noted
herein, VSV induces a reproducible CXC and CC chemo-
kine response in vivo, and CC chemokines, such as CCL5,
CCL3 and CCL4 may represent a novel mechanism for DC
polarization and T cell differentiation (Zou et al., 2000).
Whether CCL5 (RANTES), a chemokine that does not
reappear until 4 weeks after Cl2MBP-liposome treatment,
plays a role in DC maturation and VSV Th cell polarization
will require further studies in this model.
Infusion of liposome-entrapped Cl2MBP eliminates
marginal DCs and splenic mA known to be sources of
chemokines required for an inflammatory response (Megju-
gorac et al., 2004; Nakamichi et al., 2004). However, thistechnique does not ablate white pulp macrophages and
interdigitating DCs, indicating that these two populations
are not sufficient for a detectable chemokine response. A
similar argument can be made for marginal DCs and MMM
because neither of these populations reconstituted the
chemokine response following their reappearance in the
spleen. Typical macrophage activities such as phagocytosis
and production of reactive oxygen species (ROS) appeared
normal, suggesting that the failure of recently arrived MMM
to produce chemokines is not due to their functional
immaturity (data not presented). Based on repopulation
kinetics, the most likely source of chemokines is the slowly
repopulating MZM and/or RPM. This view is consistent
with preliminary studies indicating that repopulating splenic
macrophages isolated from mice treated 2 weeks previously
with Cl2MBP-liposomes and then infected with VSV
produce MIP-2 ex vivo without further re-stimulation in
vitro (data not presented). Of these two populations, we
favor a critical role for MZM because prior studies indicated
that these cells first reappeared in the spleen outside the
marginal sinus 2–3 weeks post-depletion where they were
functionally immature. Normal numbers of functionally
mature MZM located within the marginal sinus were not
achieved until several additional weeks (van Rooijen et al.,
1989, 1990). The dysregulated chemokine response detected
3 weeks post-depletion would be consistent with this view.
Unexpectedly, Cl2MBP-liposome-treated mice remained
susceptible to VSV replication even after 32 days of
recovery when DCs and most mA subpopulations have
returned to the spleen. Normally, VSV does not replicate to
detectable levels in intact mice even when given 2  109
PFU i.p. (unpublished observation). Prior studies demon-
strated that VSVactivates an interferon-producing cell (IPC)
that resides in the splenic marginal sinus via signaling
through Toll-like receptor 7 (TLR7) and the adapter protein
MyD88 (Barchet et al., 2002; Diebold et al., 2004; Lund et
al., 2004). Upon virus stimulation, CD11c+B220+Gr-1+
pDCs release massive amounts of IFN-a/h and TNFa that
establish an anti-viral state (Barchet et al., 2002; Wong and
Goeddel, 1986). However, the unexpected morbidity/mor-
tality seen with virus-infected, Cl2MBP-liposome-treated
mice did not reflect persistent depletion of interferon-
producing pDCs. Although splenic pDCs were depleted
by Cl2MBP-liposome treatment, there was no apparent
relationship between the presence of splenic pDCs and
susceptibility to VSV. For example, VSV disseminated
ubiquitously 3 and 4 weeks post-Cl2MBP-liposome treat-
ment, times when the spleen had been completely repopu-
lated with pDCs. These data suggest that either a
subpopulation of pDCs resistant to liposome-mediated
elimination exists within the host or, alternatively, that cell
types other than pDCs produce IFN in response to VSV.
With respect to the former possibility, Cl2MBP-liposome
treatment depleted CD11c+Gr-1+CD45R(B220)+ cells in
the bone marrow, blood, thymus and lymph node (data not
presented). A similar conclusion was also reached using a
R.P. Ciavarra et al. / Virology 342 (2005) 177–189 187new mAb (PDCA-1) specific for pDCs (unpublished
observation). Thus, it seems more likely that a non-
plasmacytoid dendritic cell produces type I IFN in response
to VSV. This view is consistent with the observation that
poly IC induces high titers of IFN without pDC activation
(Barchet et al., 2002). In addition, ongoing studies in a
conditional ablation transgenic mouse model indicate that
systemic depletion of DCs and pDCs fails to inhibit IFN
levels in VSV-infected animals (unpublished observation).
Although the cell type(s) producing IFN in VSV-infected
mice remains to be identified, VSV induced the expansion
of a CD11cPDCA-1+ population in the bone marrow of
both control and Cl2MBP-liposome-treated mice. The
contribution of these cells to IFN production is currently
being investigated.
As noted previously, high titers of VSV were detected in
both the spleen and liver, and both these organs displayed
gross andmicroscopic abnormalities. For example, decreased
cellularity was evident in the spleen, and livers were either
discolored (blanched) or swollen and green with engorged
gall bladders. Histological examination revealed acute
massive hepatocellular necrosis associated with neutrophilic
leukocytoclastic thrombophlebitis primarily affecting portal
veins. These lesions are similar to those reported for patients
chronically infected with hepatitis C virus (Kusano et al.,
2000). Chronic infection with this virus is associated with
portal and periportal inflammatory infiltrates composed of
DCs and T cells associated with piecemeal necrosis.
Production of CC chemokines such as DC-CK1 and
RANTES was localized to portal tracks, suggesting that the
portal tracks are sites where the anti-viral immune response is
initiated in the liver. Whether similar events in the VSV
model account for the observed portal vein pathology will
require further investigation.
This report indicates that a complex and coordinated
interplay between compartmentalized DCs, mA and their
secreted chemokines is required for induction of a primary
antiviral immune response and viral clearance. This view is
highlighted by the inability of mice with high titers of
circulating type 1 IFN to inhibit viral dissemination when
deficient of certain mf subpopulations. The inability of
mice depleted of marginal zone macrophages by Cl2MBP-
liposomes to control LCMV (Seiler et al., 1997) and
ectromelia virus (Karupiah et al., 1996) replication is
consistent with studies reported here with VSV. Similarly,
Oehen et al. (2002) reported that mice deficient of
marginal zone macrophages due to a genetic deficiency
also failed to control VSV replication despite an otherwise
normal adaptive immune response. Collectively, these
studies indicate that distinct mA populations contribute
significantly to host resistance during virus infection most
likely by elaboration of chemokines necessary to initiate
the innate and adaptive immune response and trapping of
circulating virus in secondary lymphoid organs. This
concentrates viral pathogens in lymphoid organs prevent-
ing dissemination to vital organs, a function that appearsenhanced by circulating natural antibodies (Ochsenbein
et al., 1999).Materials and methods
Mice, virus preparation, infection and generation of
primary Th cell responses in vivo
BALB/c mice (Jackson Laboratories, Bar Harbor,
Maine) were housed in sterile microisolator cages with
sterile food, water and bedding. The Institutional Animal
Care and Use Committee approved all animal studies. Wild-
type VSV (Indiana), provided by Dr. Philip Marcus,
University of Connecticut, was grown and assayed as
previously described (Marvaldi et al., 1977). Virus was
grown in confluent monolayers of Vero cells and virus titers
determined by standard plaque assays (Sekellick and
Marcus, 1979). Unless indicated otherwise, mice were
infected with VSV by a single i.p. injection of 2  107
PFU.
Liposome-mediated elimination of phagocytic cells in vivo
Prior to VSV infection, mice were depleted of splenic
DCs/mA and peritoneal mA with Cl2MBP-liposomes as
previously described (Ciavarra et al., 1997). Briefly, mice
were given two i.p injections of Cl2MBP-liposomes 72 and
24 h prior to VSV infection. In some experiments, virus
infection was delayed for the indicated times following
liposome treatment to allow for differential repopulation of
marginal DCs and splenic mA subpopulations. Cl2MBP, a
kind gift of Roche Diagnostics GmbH, Mannheim, Ger-
many, was encapsulated in liposomes as previously
described (Van Rooijen, 1989). No differences were noted
in animals treated with either PBS or liposome-entrapped
PBS. The efficacy of splenic DC/mA depletion was verified
by immunohistochemistry or flow cytometry using cell-type
specific antibodies (Van Rooijen et al., 1990).
Chemokine mRNA response
To evaluate VSV-induced chemokine mRNA responses
in vivo, mice were given a single i.p. injection of either PBS
(mock-infected) or VSV, and, at 48 h p.i., total spleen cell
RNA was isolated and probed using the RiboQuant Multi-
Probe RNase Protection Assay System developed by
Pharmingen (San Diego, CA). Protected probes were
resolved by electrophoresis on denaturing polyacrylamide
gels and detected by autoradiography. Films were scanned
with a Powerlook II Scanner (UMAX Data Systems, Inc.,
Hsinchu, Taiwan, Republic of China) and the relative
intensities of the bands quantified using a Digital Science
1D program developed by Kodak (New Haven, CT).
Similar chemokine mRNA profiles were obtained 12 h p.i.
and were omitted for clarity.
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Cytokine-producing cells were estimated by ELISPOT
assay following established procedures (Taguchi et al.,
1990). All matched capture and detection antibody pairs
were obtained either from BD Biosciences (San Diego, CA)
or eBiosciences (San Diego, CA). Spleen cells from either
mock- or VSV-infected mice were incubated overnight in
ELISPOT plates (Millipore Corporation, Bedford, MA)
containing anti-cytokine capture antibodies. No exogenous
virus was added during this incubation. The following day,
ELISPOTS were developed with horseradish-peroxidase-
conjugated avidin (Sigma Chemical Co., St. Louis, MO)
and visualized by the addition of 3-amino-9-ethylcarbazole.
Multiparameter flow cytometry
Spleens were incubated with collagenase to promote
release of DCs and mA from splenic stroma. Following
addition of unconjugated or directly conjugated antibodies
and a second wash step, unconjugated antibodies were
detected using a biotin-conjugated anti-rat IgG followed by
fluorescein (FITC)-conjugated streptavidin. Splenic DCs
and mA subpopulations were identified using antibodies to
DCs (CD11c/N418, Pharmingen), RPM (F4/80), MMM
(MOMA-1, SER4) (Kraal and Janse, 1986) and MZM
(ERTR9) (Dijkstra et al., 1985). Antibodies to mA
subpopulations were also obtained either from G. Kraal,
Department of Molecular Cell Biology, Vrije Universiteit,
Amsterdam, The Netherlands (ERTR9 and MOMA-1), Paul
Crocker, Sir William Dunn School of Pathology, Oxford,
UK (SER-4) (Crocker et al., 1990) or commercial sources
(F4/80, Serotec, Raleigh, NC). Flow cytometric analysis of
20–200,000 events per sample was performed on a
FACScan (Becton-Dickinson, Mountain View, CA) using
CELL Quest software (Becton-Dickinson). Gates were set
with the use of appropriate isotype controls.Acknowledgments
This work was supported by grants from the National
Institutes of Health (AI47800) (RPC), Jeffress Memorial
Trust (RPC) and by the Eastern Virginia Medical School
Institutional Grant 868030 (RPC).References
Barchet, W., Cella, M., Odermatt, B., Asselin-Paturel, C., Colonna, M.,
Kalinke, U., 2002. Virus-induced interferon alpha production by a
dendritic cell subset in the absence of feedback signaling in vivo. J. Exp.
Med. 195 (4), 507–516.
Buiting, A.M., De Rover, Z., Kraal, G., Van Rooijen, N., 1996. Humoral
immune responses against particulate bacterial antigens are dependent
on marginal metallophilic macrophages in the spleen. Scand. J.
Immunol. 43 (4), 398–405.Ciavarra, R.P., Tedeschi, B., 1994. Priming antiviral cytotoxic T lympho-
cytes: requirement for CD4+ cells is dependent on the antigen
presenting cell in vivo. Cell Immunol. 157 (1), 132–143.
Ciavarra, R.P., Buhrer, K., Van Rooijen, N., Tedeschi, B., 1997. T
cell priming against vesicular stomatitis virus analyzed in situ: red
pulp macrophages, but neither marginal metallophilic nor marginal
zone macrophages, are required for priming CD4+ and CD8+ T
cells. J. Immunol. 158 (4), 1749–1755.
Ciavarra, R.P., Greene, A.R., Horeth, D.R., Buhrer, K., van Rooijen, N.,
Tedeschi, B., 2000. Antigen processing of vesicular stomatitis virus in
situ. Interdigitating dendritic cells present viral antigens independent of
marginal dendritic cells but fail to prime CD4 (+) and CD8 (+) T cells.
Immunology 101 (4), 512–520.
Crocker, P.R., Werb, Z., Gordon, S., Bainton, D.F., 1990. Ultrastructural
localization of a macrophage-restricted sialic acid binding hemaggluti-
nin, SER, in macrophage-hematopoietic cell clusters. Blood 76 (6),
1131–1138.
Cua, D.J., Hinton, D.R., Kirkman, L., Stohlman, S.A., 1995. Macrophages
regulate induction of delayed-type hypersensitivity and experimental
allergic encephalomyelitis in SJL mice. Eur. J. Immunol. 25 (8),
2318–2324.
de Jong, E.C., Vieira, P.L., Kalinski, P., Schuitemaker, J.H., Tanaka, Y.,
Wierenga, E.A., Yazdanbakhsh, M., Kapsenberg, M.L., 2002. Microbial
compounds selectively induce Th1 cell-promoting or Th2 cell-promoting
dendritic cells in vitro with diverse th cell-polarizing signals. J. Immu-
nol. 168 (4), 1704–1709.
De Smedt, T., Butz, E., Smith, J., Maldonado-Lopez, R., Pajak, B., Moser,
M., Maliszewski, C., 2001. CD8alpha () and CD8alpha (+) subclasses
of dendritic cells undergo phenotypic and functional maturation in vitro
and in vivo. J. Leukocyte Biol. 69 (6), 951–958.
Delemarre, F.G., Kors, N., van Rooijen, N., 1990. Elimination of spleen
and of lymph node macrophages and its difference in the effect on
the immune response to particulate antigens. Immunobiology 182
(1), 70–78.
Diebold, S.S., Kaisho, T., Hemmi, H., Akira, S., Reis e Sousa, C., 2004.
Innate antiviral responses by means of TLR7-mediated recognition of
single-stranded RNA. Science 303 (5663), 1529–1531.
Dijkstra, C.D., Van Vliet, E., Dopp, E.A., van der Lelij, A.A., Kraal, G.,
1985. Marginal zone macrophages identified by a monoclonal antibody:
characterization of immuno- and enzyme-histochemical properties and
functional capacities. Immunology 55 (1), 23–30.
Huang, L.Y., Reis e Sousa, C., Itoh, Y., Inman, J., Scott, D.E., 2001. IL-12
induction by a TH1-inducing adjuvant in vivo: dendritic cell subsets and
regulation by IL-10. J. Immunol. 167 (3), 1423–1430.
Kadowaki, N., Liu, Y.J., 2002. Natural type I interferon-producing cells as a
link between innate and adaptive immunity. Hum. Immunol. 63 (12),
1126–1132.
Karupiah, G., Buller, R.M., Van Rooijen, N., Duarte, C.J., Chen, J., 1996.
Different roles for CD4+ and CD8+ T lymphocytes and macrophage
subsets in the control of a generalized virus infection. J. Virol. 70 (12),
8301–8309.
Kraal, G., 1992. Cells in the marginal zone of the spleen. Int. Rev. Cytol.
132, 31–74.
Kraal, G., Janse, M., 1986. Marginal metallophilic cells of the mouse spleen
identified by a monoclonal antibody. Immunology 58 (4), 665–669.
Kusano, F., Tanaka, Y., Marumo, F., Sato, C., 2000. Expression of C-C
chemokines is associated with portal and periportal inflammation in the
liver of patients with chronic hepatitis C. Lab. Invest. 80 (3), 415–422.
Leenen, P.J., Radosevic, K., Voerman, J.S., Salomon, B., van Rooijen,
N., Klatzmann, D., van Ewijk, W., 1998. Heterogeneity of mouse
spleen dendritic cells: in vivo phagocytic activity, expression of
macrophage markers, and subpopulation turnover. J. Immunol. 160
(5), 2166–2173.
Lopez, C.B., Fernandez-Sesma, A., Schulman, J.L., Moran, T.M., 2001.
Myeloid dendritic cells stimulate both Th1 and Th2 immune responses
depending on the nature of the antigen. J. Interferon. Cytokine Res. 21
(9), 763–773.
R.P. Ciavarra et al. / Virology 342 (2005) 177–189 189Lund, J.M., Alexopoulou, L., Sato, A., Karow, M., Adams, N.C., Gale,
N.W., Iwasaki, A., Flavell, R.A., 2004. Recognition of single-stranded
RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. U.S.A. 101
(15), 5598–5603.
Maldonado-Lopez, R., De Smedt, T., Michel, P., Godfroid, J., Pajak, B.,
Heirman, C., Thielemans, K., Leo, O., Urbain, J., Moser, M., 1999.
CD8alpha+ and CD8alpha-subclasses of dendritic cells direct the
development of distinct T helper cells in vivo. J. Exp. Med. 189 (3),
587–592.
Marvaldi, J.L., Lucas-Lenard, J., Sekellick, M.J., Marcus, P.I., 1977. Cell
killing by viruses. IV. Cell killing and protein synthesis inhibition by
vesicular stomatitis virus require the same gene functions. Virology 79
(2), 267–280.
Matsushima, G.K., Stohlman, S.A., 1991. Distinct subsets of accessory
cells activate Thy-1+ triple negative (CD3, CD4, CD8) cells and
Th-1 delayed-type hypersensitivity effector T cells. J. Immunol. 146
(10), 3322–3331.
Megjugorac, N.J., Young, H.A., Amrute, S.B., Olshalsky, S.L.,
Fitzgerald-Bocarsly, P., 2004. Virally stimulated plasmacytoid den-
dritic cells produce chemokines and induce migration of T and NK
cells. J. Leukocyte Biol. 75 (3), 504–514.
Nakamichi, K., Inoue, S., Takasaki, T., Morimoto, K., Kurane, I., 2004.
Rabies virus stimulates nitric oxide production and CXC chemokine
ligand 10 expression in macrophages through activation of extracellular
signal-regulated kinases 1 and 2. J. Virol. 78 (17), 9376–9388.
Ochsenbein, A.F., Fehr, T., Lutz, C., Suter, M., Brombacher, F., Hengartner,
H., Zinkernagel, R.M., 1999. Control of early viral and bacterial
distribution and disease by natural antibodies. Science 286 (5447),
2156–2159.
Oehen, S., Odermatt, B., Karrer, U., Hengartner, H., Zinkernagel, R.,
Lopez-Macias, C., 2002. Marginal zone macrophages and immune
responses against viruses. J. Immunol. 169 (3), 1453–1458.
Salazar-Mather, T.P., Hamilton, T.A., Biron, C.A., 2000. A chemokine-to-
cytokine-to-chemokine cascade critical in antiviral defense. J. Clin.
Invest. 105 (7), 985–993.
Seiler, P., Aichele, P., Odermatt, B., Hengartner, H., Zinkernagel, R.M.,
Schwendener, R.A., 1997. Crucial role of marginal zone macro-phages and marginal zone metallophils in the clearance of
lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 27
(10), 2626–2633.
Sekellick, M.J., Marcus, P.I., 1979. Persistent infection: II. Interferon-
inducing temperature-sensitive mutants as mediators of cell sparing:
possible role in persistent infection by vesicular stomatitis virus.
Virology 95 (1), 36–47.
Shedlock, D.J., Shen, H., 2003. Requirement for CD4 T cell help in
generating functional CD8 T cell memory. Science 300 (5617),
337–339.
Sun, J.C., Bevan, M.J., 2003. Defective CD8 T cell memory following
acute infection without CD4 T cell help. Science 300 (5617), 339–342.
Taguchi, T., McGhee, J.R., Coffman, R.L., Beagley, K.W., Eldridge,
J.H., Takatsu, K., Kiyono, H., 1990. Detection of individual mouse
splenic T cells producing IFN-gamma and IL-5 using the enzyme-
linked immunospot (ELISPOT) assay. J. Immunol. Methods 128 (1),
65–73.
Van Rooijen, N., 1989. The liposome-mediated macrophage Fsuicide_
technique. J. Immunol. Methods 124 (1), 1–6.
van Rooijen, N., Kors, N., Kraal, G., 1989. Macrophage subset repopula-
tion in the spleen: differential kinetics after liposome-mediated
elimination. J. Leukocyte Biol. 45 (2), 97–104.
Van Rooijen, N., Kors, N., vd Ende, M., Dijkstra, C.D., 1990. Depletion
and repopulation of macrophages in spleen and liver of rat after
intravenous treatment with liposome-encapsulated dichloromethylene
diphosphonate. Cell Tissue Res. 260 (2), 215–222.
Whelan, M., Harnett, M.M., Houston, K.M., Patel, V., Harnett, W.,
Rigley, K.P., 2000. A filarial nematode-secreted product signals
dendritic cells to acquire a phenotype that drives development of
Th2 cells. J. Immunol. 164 (12), 6453–6460.
Wong, G.H., Goeddel, D.V., 1986. Tumour necrosis factors alpha and beta
inhibit virus replication and synergize with interferons. Nature 323
(6091), 819–822.
Zou, W., Borvak, J., Marches, F., Wei, S., Galanaud, P., Emilie, D., Curiel,
T.J., 2000. Macrophage-derived dendritic cells have strong Th1-
polarizing potential mediated by beta-chemokines rather than IL-12.
J. Immunol. 165 (8), 4388–4396.
